What is PRQR's relative strength rating?

PRQR ranks at the 95th percentile over 1 month, 95th percentile over 3 months, 92th percentile over 6 months, 55th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is PRQR in?

PRQR is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is PRQR in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). PRQR benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is PRQR?

PRQR currently shows a 20-day average daily range (ADR%) of 6.6%, a 90-day beta versus the S&P 500 of 1.80. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does PRQR have a seasonal pattern?

TickerStance computes PRQR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what PRQR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did PRQR last report earnings?

No SEC EDGAR filings are linked to PRQR in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

ProQR Therapeutics N.V. Ordinary Shares (PRQR)

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, ProQR Therapeutics N.V. Ordinary Shares (PRQR) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.6%, relative volume 1.24×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month95pctile

6 month92pctile

1 year55pctile

Classic86IBD pctile

LDR81leadership

0 of 5 lenses lit · avg RS pctile 82

✓ADR%6.6%✓A/DB!RVOL1.24×!$ Vol$2M

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2022

Best monthDec on averageavg +45.97% · 50% win · n 4

Worst monthJan on averageavg -13.95% · 25% win · n 4

PRQR monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	PRQR Jan avg: -13.95% median: -19.99% win: 25% σ: 15.90% n: 4 2022-04-12 → 2026-07-31	PRQR Feb avg: 2.01% median: 2.52% win: 50% σ: 7.94% n: 4 2022-04-12 → 2026-07-31	PRQR Mar avg: -13.80% median: -12.96% win: 50% σ: 26.10% n: 4 2022-04-12 → 2026-07-31	PRQR Apr avg: -3.33% median: -3.09% win: 40% σ: 19.08% n: 5 2022-04-12 → 2026-07-31	PRQR May avg: -4.76% median: 0.00% win: 40% σ: 8.91% n: 5 2022-04-12 → 2026-07-31	PRQR Jun avg: 7.34% median: 17.72% win: 60% σ: 17.00% n: 5 2022-04-12 → 2026-07-31	PRQR Jul avg: 2.40% median: 2.94% win: 60% σ: 10.19% n: 5 2022-04-12 → 2026-07-31	PRQR Aug avg: 3.28% median: 5.83% win: 75% σ: 6.09% n: 4 2022-04-12 → 2026-07-31 (current)	PRQR Sep avg: -10.01% median: -7.86% win: 0% σ: 6.33% n: 4 2022-04-12 → 2026-07-31	PRQR Oct avg: 33.55% median: 26.72% win: 75% σ: 43.17% n: 4 2022-04-12 → 2026-07-31	PRQR Nov avg: 15.64% median: 21.34% win: 75% σ: 23.34% n: 4 2022-04-12 → 2026-07-31	PRQR Dec avg: 45.97% median: 7.03% win: 50% σ: 106.13% n: 4 2022-04-12 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

3 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

95

3m

95

6m

92

1y

55

LDR

—

StageWeinstein stage analysis

Stage 1 · Basing

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · PRQR

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
PRQR
95RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

BFRIBiofrontera Inc. Common Stock92 OMEROmeros Corporation92 XBIOXenetic Biosciences, Inc.92 INMInMed Pharmaceuticals Inc. Common Shares92

ETF OWNERS

ETFs holding PRQR

PRQR appears in 1 ETF as of May 2026: QQQS at 0.40% weight, $76K notional.

Held by 1 ETFs · $76K across latest filings · largest weight 0.40% (QQQS).

ETFs holding: 1
Total value: $76K
Top 3 concentration: 100.0%
Max weight: QQQS · 0.40%

Top 1 by value, from SEC N-PORT-P filings dated May 2026.

ETFs holding PRQR ranked by value
ETF	Weight	Value	Δ
QQQS	0.40%	$76K	+0.08 pp

QQQS added +0.08 pp

As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.

Public attention · PRQR

Is the crowd watching?

57/ 100 · vs its own 90-day norm▲ 57 vs 7dStealth leader

Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float86.8Mshares

Shares out141.1Mshares

Market cap$342.9MSmall Cap

FAQ

Frequently asked questions

What is PRQR's relative strength rating?: PRQR ranks at the 95th percentile over 1 month, 95th percentile over 3 months, 92th percentile over 6 months, 55th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is PRQR in?: PRQR is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is PRQR in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). PRQR benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is PRQR?: PRQR currently shows a 20-day average daily range (ADR%) of 6.6%, a 90-day beta versus the S&P 500 of 1.80. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does PRQR have a seasonal pattern?: TickerStance computes PRQR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what PRQR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

ProQR Therapeutics N.V. Ordinary Shares (PRQR) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding PRQR

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

ProQR Therapeutics N.V. Ordinary Shares (PRQR) — Stance & relative strength

PRQR is on the watchlist, not confirmed. 3m RS is 95, Market Stance is mixed at 47.8, A/D rating B

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding PRQR

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?